University Of Eastern Finland
- Address
- lock Available on a paid plan
Nervous System Diseases Research
The University Of Eastern Finland Brain Research Unit is conducting clinical trials focused on nervous system diseases, with a strong emphasis on Alzheimer’s disease and related cognitive disorders. The studies are designed to assess whether new treatments can improve memory, thinking, and daily functioning, while also examining longer-term safety and tolerability in people living with early and mild-to-moderate stages of the disease.
- Early and mild-to-moderate Alzheimer’s disease
- Mild cognitive impairment and mild dementia of the Alzheimer’s type
- Testing new therapies and evaluating treatment effectiveness
This research landscape reflects an active effort in Kuopio to advance care for neurodegenerative conditions and to better understand how emerging therapies may support cognition and function.
Psychiatry and Psychology Studies
Clinical research at this site also connects to psychiatry and psychology, especially where mental disorders overlap with cognitive decline and brain health. The trials are exploring whether novel medicines can improve overall cognitive performance and global functioning in people affected by Alzheimer’s-related impairment.
- Cognitive impairment linked to Alzheimer’s disease
- Functional decline in people with early memory disorders
- Improving diagnostic and treatment outcomes for brain-related disorders
These studies highlight a broader interest in how brain and behavior-related conditions can be treated more effectively through innovative clinical research.
Neurodegenerative Disease Trials
Another important area of work at the Brain Research Unit is the study of amyotrophic lateral sclerosis. These trials are investigating whether new treatments can help people with both sporadic and familial forms of the disease, with attention to safety, tolerability, and potential clinical benefit over time.
- Amyotrophic lateral sclerosis in sporadic and familial forms
- Assessing new approaches for a serious progressive neurological disease
- Supporting long-term treatment evaluation
Together, these studies show that the University Of Eastern Finland is contributing to research aimed at slowing disease impact and improving quality of life for patients with challenging neurological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Biogen Idec Research Limited1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Biogen Idec Research Limited2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of Eastern Finland
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia | Biogen Idec Research Limited | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Florbetaben (18F) | 3 | Unknown | 2023-09-28 | 2024-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.